Annotation Detail for ELAVL4
Basic Information
Top
| Gene Symbol: | ELAVL4 ( HUD,PNEM ) |
|---|
| Gene Full Name: | ELAV (embryonic lethal, abnormal vision, Drosophila)-like 4 (Hu antigen D) |
|---|
| Band: | 1p33-p32.3 |
|---|
| Quick Links | Entrez ID:1996; OMIM: 168360; Uniprot ID:ELAV4_HUMAN; ENSEMBL ID: ENSG00000162374; HGNC ID: 3315 |
|---|
| Relate to Another Database: |
SFARIGene;
denovo-db |
| Desease ID | Desease Name |
|---|
| 1709 | Parkinson disease |
| 2151 | Neuroblastoma |
| 2257 | Hemolytic-Uremic syndrome |
| Desease Name |
|---|
| Neuropathy, paraneoplastic sensory |
| Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
|---|
| D000643 |
Ammonium Chloride |
Ammonium Chloride affects the expression of ELAVL4 mRNA | affects expression | 16483693
|
| C020771 |
methylmercury hydroxide |
methylmercury hydroxide results in increased expression of ELAVL4 mRNA | increases expression | 20493249
|
| D008942 |
Mitoxantrone |
ELAVL4 mRNA affects the susceptibility to Mitoxantrone | affects response to substance | 16044152
|
| C076994 |
perfluorooctane sulfonic acid |
perfluorooctane sulfonic acid results in increased expression of ELAVL4 protein | increases expression | 19474218
|
| C017947 |
sodium arsenite |
sodium arsenite affects the expression of ELAVL4 mRNA | affects expression | 19590694
|
| Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
|---|
| MESH:D000138 |
Acidosis |
|
Ammonium Chloride |
4.10 | 18287403 |
| MESH:D000310 |
Adrenal Gland Neoplasms |
|
sodium arsenite |
5.31 | 15276417 |
| MESH:D018246 |
Adrenocortical Adenoma |
|
sodium arsenite |
5.51 | 17306315 16712894 |
| MESH:D006528 |
Carcinoma, Hepatocellular |
|
sodium arsenite |
2.00 | 17306315 15276417 16507464 |
| MESH:D002294 |
Carcinoma, Squamous Cell |
|
sodium arsenite |
2.46 | 18572023 |
| MESH:D002471 |
Cell Transformation, Neoplastic |
|
sodium arsenite |
3.22 | 20056578 19524636 |
| MESH:D005833 |
Genital Neoplasms, Female |
|
sodium arsenite |
5.22 | 16452187 |
| MESH:D005909 |
Glioblastoma |
|
perfluorooctane sulfonic acid |
4.47 | 17162496 |
| MESH:D006331 |
Heart Diseases |
|
Mitoxantrone |
4.39 | 16019553 |
| MESH:D006689 |
Hodgkin Disease |
|
sodium arsenite |
3.47 | 12676792 |
| MESH:D007248 |
Infertility, Male |
|
sodium arsenite |
3.21 | 15346721 12646999 |
| MESH:D007674 |
Kidney Diseases |
|
sodium arsenite |
2.98 | 20008137 |
| MESH:D015451 |
Leukemia, Lymphocytic, Chronic, B-Cell |
|
Mitoxantrone |
3.91 | 18172266 |
| MESH:D008113 |
Liver Neoplasms |
|
sodium arsenite |
2.47 | 15276417 16712894 |
| MESH:D008171 |
Lung Diseases |
|
sodium arsenite |
3.40 | 19095001 |
| MESH:D008175 |
Lung Neoplasms |
|
sodium arsenite |
1.90 | 16712894 19931552 17306315 17077188 15276417 |
| MESH:D008545 |
Melanoma |
|
sodium arsenite |
2.07 | 16487513 19082730 |
| MESH:D009369 |
Neoplasms |
|
Mitoxantrone |
5.99 | 16640825 |
| MESH:D009369 |
Neoplasms |
|
sodium arsenite |
5.99 | 11559025 |
| MESH:D009374 |
Neoplasms, Experimental |
|
sodium arsenite |
4.15 | 20056578 |
| MESH:D009436 |
Neural Tube Defects |
|
sodium arsenite |
3.36 | 12854658 |
| MESH:D010051 |
Ovarian Neoplasms |
|
sodium arsenite |
2.52 | 17306315 15276417 |
| MESH:D011471 |
Prostatic Neoplasms |
|
sodium arsenite |
3.24 | 16039940 |
| MESH:D012878 |
Skin Neoplasms |
|
sodium arsenite |
2.84 | 19524636 18572023 |
| MESH:D016135 |
Spinal Dysraphism |
|
sodium arsenite |
4.07 | 12854658 |
| MESH:D001749 |
Urinary Bladder Neoplasms |
|
sodium arsenite |
2.62 | 16452187 16712894 17306315 11723127 |
| MESH:D002583 |
Uterine Cervical Neoplasms |
|
sodium arsenite |
4.11 | 11813266 |
| MESH:D014652 |
Vascular Diseases |
|
sodium arsenite |
4.96 | 17056641 |
Related Pathway Information